Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Chamberlain

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Neurology|May 24, 2000
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyM J Glantz, B F Cole, P A Forsyth, et al.
Cancer Treatment Reports|May 1, 1987
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumorsV A Levin, M C Chamberlain, M D Prados, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsM J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group ReportS A Grimm, J S Pulido, K Jahnke, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Neurology|May 24, 2000
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyM J Glantz, B F Cole, P A Forsyth, et al.
Cancer Treatment Reports|May 1, 1987
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumorsV A Levin, M C Chamberlain, M D Prados, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsM J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group ReportS A Grimm, J S Pulido, K Jahnke, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Pageof 9